The influence of brand principle display panel (PDP) for safe consumer use of over-the-counter drugs advancing the science.

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201510126C
Awardee
Awarding agency
Obligated
$286,937

Award facts

Opportunity
Contract value 100% obligated
$286,937.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Evanston, IL 60208, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 9 $0
Supplemental Agreement for work within scope 8 $0
Supplemental Agreement for work within scope 7 $0
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Exercise an Option 4 $138,618
Supplemental Agreement for work within scope 3 · The influence of brand principal display panel (PDP) for safe consumer use of over-the-counter drugs advancing the science. $0
Additional Work (new agreement, FAR part 6 applies) 2 $0
Other Administrative Action 1 $0
Original award $148,319

About this award

This is a definitive contract awarded by the Food and Drug Administration (FDA) to Northwestern University, a private research university, for a study on the influence of brand principle display panels (PDPs) on the safe consumer use of over-the-counter (OTC) drugs. The $286,937 firm fixed-price contract has a performance period ending on December 31, 2018.

The study involves conducting mixed-methods research to understand how brand image, familiarity, and display panel labeling impact consumer product self-selection, understanding of active ingredients, and intended use of OTC medications. Emory University is a major subcontractor, with Professor Ruth Parker collaborating with the principal investigator, Dr. Michael Wolf of Northwestern, to develop the study protocol and methodology. The findings from this research are expected to inform the FDA's understanding of brand extensions, an area of current interest for the agency.

Quick answers

Who was awarded contract HHSF223201510126C?

HHSF223201510126C was awarded to Northwestern University by Food and Drug Administration (Department of Health and Human Services) on September 14, 2015.

How much is contract HHSF223201510126C worth?

The government has obligated $286,937 on HHSF223201510126C.

Was contract HHSF223201510126C competed?

The extent of competition for HHSF223201510126C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award